Skip to main content

All conditions for the Subscription Guarantee in Ortivus AB’s ongoing Rights Issue now fulfilled

2025-10-09 16:00

In the press release dated 25 August 2025, it was stated, among other things, that the subscription guarantee provided by Ponderus Invest AB in connection with the ongoing rights issue, as resolved by the Extraordinary General Meeting held on 19 September 2025, was conditional upon the Swedish Inspectorate of Strategic Products (ISP), in accordance with the Act (2023:560) on the Screening of Foreign Direct Investments (FDI), issuing a decision that no review was required, or, if a review were undertaken, approving the investment that could result from the fulfilment of the guarantee.

The ISP has now notified that Ponderus Invest AB’s FDI application does not give rise to any review. Consequently, the subscription guarantee provided by Ponderus Invest AB in respect of the rights issue is no longer subject to any conditions.

Get in touch

Empower your team with smarter solutions

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required